The Neuroscience Journal
Gene-Modified Cell-Based Therapy for AD prior to transplantation can be beneficial for increasing cell survival and making them more effective, and adapted cells could be used for the transfer of factors that can ameliorate neurological complaints.
Z. Hosseini
· 0 citations